Search research articles
Contact Us
Filters
Showing results (131-140 of 175) with videos related to
Page
of 18
Sort By:
Nature Communications
|
September 10, 2017
HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells
Daniela Cesana, Francesca R Santoni de Sio, Laura Rudilosso, et al.
Open Forum Infectious Diseases
|
March 18, 2026
Early Combination Antiretroviral Therapy Initiation During Primary HIV Infection Restricts HIV Reservoirs and Gut-Driven Inflammation but Fails to Rewire the Systemic Cytokine Landscape
Valeria Bono, Camilla Tincati, Matteo Augello, et al.
Emerging Microbes & Infections
|
April 4, 2024
Evaluation of analytical performance of the STANDARD<sup>TM</sup> M10 MPX/OPX assay for the simultaneous DNA detection and clade attribution of <i>Monkeypox virus</i>
Alessandro Mancon, Angelo Roberto Raccagni, Gloria Gagliardi, et al.
Frontiers in Immunology
|
March 28, 2019
Seminal Plasma Exposures Strengthen Vaccine Responses in the Female Reproductive Tract Mucosae
Romain Marlin, Marie-Thérèse Nugeyre, Nicolas Tchitchek, et al.
AIDS (London, England)
|
November 28, 2023
Primary HIV infection features colonic damage and neutrophil inflammation yet containment of microbial translocation
Camilla Tincati, Valeria Bono, Elvira Stefania Cannizzo, et al.
Plos One
|
October 18, 2019
Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort
Emanuele Focà, Paola Magro, Giovanni Guaraldi, et al.
International Journal of Antimicrobial Agents
|
May 20, 2024
Plasma, intracellular and lymph node antiretroviral concentrations and HIV DNA change during primary HIV infection: Results from the INACTION P25 study
Amedeo De Nicolò, Alice Palermiti, Stefania Dispinseri, et al.
The New Microbiologica
|
May 27, 2014
Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodology
Simone Marcotullio, Adriana Ammassari, Massimo Andreoni, et al.
Pathogens & Immunity
|
November 21, 2025
Three-Month cART Initiated During Primary HIV Does Not Correct the Structural, Immune, and Microbial Abnormalities within the Gastrointestinal Tract
Camilla Tincati, Valeria Bono, Silvia Nozza, et al.
AIDS (London, England)
|
February 9, 2016
Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment
Hans-Jürgen Stellbrink, Eric Le Fevre, Andrew Carr, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 175) with videos related to
Sort By:
Page
of 18
Nature Communications
|
September 10, 2017
HIV-1-mediated insertional activation of STAT5B and BACH2 trigger viral reservoir in T regulatory cells
Daniela Cesana, Francesca R Santoni de Sio, Laura Rudilosso, et al.
Open Forum Infectious Diseases
|
March 18, 2026
Early Combination Antiretroviral Therapy Initiation During Primary HIV Infection Restricts HIV Reservoirs and Gut-Driven Inflammation but Fails to Rewire the Systemic Cytokine Landscape
Valeria Bono, Camilla Tincati, Matteo Augello, et al.
Emerging Microbes & Infections
|
April 4, 2024
Evaluation of analytical performance of the STANDARD<sup>TM</sup> M10 MPX/OPX assay for the simultaneous DNA detection and clade attribution of <i>Monkeypox virus</i>
Alessandro Mancon, Angelo Roberto Raccagni, Gloria Gagliardi, et al.
Frontiers in Immunology
|
March 28, 2019
Seminal Plasma Exposures Strengthen Vaccine Responses in the Female Reproductive Tract Mucosae
Romain Marlin, Marie-Thérèse Nugeyre, Nicolas Tchitchek, et al.
AIDS (London, England)
|
November 28, 2023
Primary HIV infection features colonic damage and neutrophil inflammation yet containment of microbial translocation
Camilla Tincati, Valeria Bono, Elvira Stefania Cannizzo, et al.
Plos One
|
October 18, 2019
Elderly HIV-positive women: A gender-based analysis from the Multicenter Italian "GEPPO" Cohort
Emanuele Focà, Paola Magro, Giovanni Guaraldi, et al.
International Journal of Antimicrobial Agents
|
May 20, 2024
Plasma, intracellular and lymph node antiretroviral concentrations and HIV DNA change during primary HIV infection: Results from the INACTION P25 study
Amedeo De Nicolò, Alice Palermiti, Stefania Dispinseri, et al.
The New Microbiologica
|
May 27, 2014
Less drug regimens and PI/r-based strategies in HIV infection: focus on best practices using the HIV patient's journey methodology
Simone Marcotullio, Adriana Ammassari, Massimo Andreoni, et al.
Pathogens & Immunity
|
November 21, 2025
Three-Month cART Initiated During Primary HIV Does Not Correct the Structural, Immune, and Microbial Abnormalities within the Gastrointestinal Tract
Camilla Tincati, Valeria Bono, Silvia Nozza, et al.
AIDS (London, England)
|
February 9, 2016
Once-daily maraviroc versus tenofovir/emtricitabine each combined with darunavir/ritonavir for initial HIV-1 treatment
Hans-Jürgen Stellbrink, Eric Le Fevre, Andrew Carr, et al.
Page
of 18